Key Takeaways & Executive Findings
- •• • The 2025 Chinese Pharmacopoeia classifies highly toxic medicinal materials into a 3-tier system (highly toxic, toxic, mildly toxic), inheriting Li Shizhen's 4-tier classification from Bencao Gangmu; this regulatory framework imposes strict clinical constraints including pregnancy contraindications, compatibility禁忌, and dosage limits, directly impacting prescribing practices for over 50 identified high-toxicity compounds such as aconitine alkaloids and brucine. • • HPLC-MS-based fingerprinting has successfully identified more than 50 highly toxic constituents across these materials, enabling qualitative and quantitative analysis; this analytical capability is critical for batch-to-batch quality control, as therapeutic windows are extremely narrow—therapeutic and toxic doses are nearly identical, risking multi-organ failure and death. • • Mechanistic studies using apoptotic signaling pathways and metabolomics have uncovered 'biphasic toxicity effects,' where toxicity and efficacy are dose-dependent and interconvertible; this bidirectional toxicity-efficacy relationship necessitates precise dosage optimization to avoid therapeutic failure or adverse reactions, as demonstrated in cardiotoxicity evaluations of aconitine using heart-on-a-particle microfluidic devices. • • Traditional processing (paozhi) and compatibility (peiwu) detoxification strategies have been scientifically validated; for example, controlled processing conditions promote conversion of toxic alkaloids, significantly reducing toxicity while preserving efficacy, as shown in studies on Chuanwu where different processed products were evaluated for 'toxicity reduction-efficacy preservation,' providing a scalable approach for industrial production.
China Biomedical & Cell Therapy Radar
Get verified English translations, SEM micrographs & open-access PDF alerts from China's leading state key laboratories delivered to your inbox every Monday at 08:00 EST.
Abstract
The toxicity of traditional Chinese medicines (TCMs) constitutes a core component of pharmacological theory, alongside the four natures and five flavors, ascending-descending-floating-sinking, and channel tropism, collectively guiding clinical TCM practice. Highly toxic medicinal materials present formidable challenges: their complex compositions impede full elucidation of toxic constituents and mechanisms, while diverse clinical regimens and significant individual variability further complicate research. This review systematically examines highly toxic medicinal materials listed in the 2025 edition of the Chinese Pharmacopoeia. Integrating herbal textual research with modern pharmacological investigations, it analyzes common toxic components and pathways, the bidirectional toxicity-efficacy relationship, and strategies for reducing toxicity while preserving efficacy. The application of modern analytical detection techniques in quality control is reviewed, and other potentially toxic substances and risk management strategies are discussed. The 2025 Pharmacopoeia classifies highly toxic materials primarily as plant-derived, imposing strict regulations on dosage forms, pregnancy contraindications, compatibility contraindications, usage, and special population restrictions. Historical toxicity grading has evolved; for instance, Chuanwu (Aconiti Lateralis Radix Praeparata) was recorded as 'toxic' in Wupu Bencao but as 'highly toxic' in Mingyi Bielu and Yaoxing Lun. Advanced analytical tools such as HPLC-MS have enabled fingerprinting and identification of over 50 highly toxic compounds, including aconitine-type alkaloids and brucine. Mechanistic studies based on apoptotic signaling pathways and metabolomics have revealed complex 'biphasic toxicity effects.' Traditional processing detoxification and compatibility antagonism have been scientifically validated and optimized. However, challenges persist, particularly the incomplete 'component-toxicity' association, which restricts clinical dosage ranges and elevates potential risks, constraining further clinical application. This review aims to provide a scientific reference for deepening quality standard research and promoting safe, rational clinical use of highly toxic medicinal materials.
1. Introduction
Clinical application of highly toxic traditional Chinese medicinal materials has long been constrained by a narrow therapeutic index, where the margin between therapeutic and toxic doses is minimal, risking severe multi-organ failure or death. Existing quality control approaches, primarily reliant on empirical processing and compatibility, lack comprehensive understanding of toxic constituents and mechanisms, leading to inconsistent detoxification and unpredictable clinical outcomes. The complexity of these materials, combined with diverse medication regimens and individual variability, has stalled efforts to establish robust safety profiles, limiting their integration into modern healthcare systems.
This review addresses these bottlenecks by systematically analyzing highly toxic materials listed in the 2025 Chinese Pharmacopoeia, integrating herbal textual research with modern pharmacological data. By elucidating common toxic components and pathways, the bidirectional toxicity-efficacy relationship, and optimized detoxification strategies, the study provides a framework for enhancing quality standards and clinical safety. Advanced analytical techniques such as HPLC-MS enable precise fingerprinting of over 50 toxic compounds, while mechanistic insights from apoptotic signaling and metabolomics inform dosage optimization. The proposed strategies aim to expand therapeutic applications while mitigating risks, offering a scientific basis for regulatory and clinical decision-making.
Loading authentic research manuscript (Pages 1–5)...
DENG Lulu, ZHAO Zhigao, WU Shuyu, JIA Lei, TAN Rui (2026). Advances in Toxicity Risk Control and Modern Research of Highly Toxic Traditional Chinese Medicinal Materials. Chinese Traditional and Herbal Drugs. https://doi.org/10.7501/j.issn.0253-2670.2026.16.20261634
Research & Educational Purpose Only: The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioDataare intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What are the primary failure mechanisms of current detoxification methods for highly toxic TCM materials under clinical stress?
Current detoxification methods, such as traditional processing and compatibility, often fail due to incomplete conversion of toxic alkaloids. For instance, in Chuanwu, improper processing conditions can leave residual aconitine levels exceeding safe thresholds, leading to cardiotoxicity. Studies show that even after processing, toxic alkaloids like aconitine, mesaconitine, and hypaconitine can persist, with metabolic products retaining toxicity. The narrow therapeutic window means that minor variations in processing or patient metabolism can precipitate severe adverse events, as evidenced by accidental poisoning from improperly prepared medicinal liquors.
How do modern analytical techniques like HPLC-MS improve quality control compared to legacy methods?
HPLC-MS enables qualitative and quantitative analysis of over 50 highly toxic compounds, constructing precise fingerprints that legacy methods cannot achieve. This allows for detection of trace toxic constituents, such as aconitine alkaloids and brucine, at concentrations as low as nanograms per milliliter. In contrast, traditional methods rely on subjective organoleptic evaluation and lack sensitivity, leading to batch variability. HPLC-MS data facilitate setting stringent limits, ensuring batch-to-batch consistency and reducing clinical risks associated with dose-dependent toxicity.
What are the scalability bottlenecks for industrial production of detoxified highly toxic TCM materials?
Scalability is hindered by the need for precise control of processing parameters, such as temperature, pressure, and duration, to achieve consistent alkaloid conversion. For example, in Chuanwu processing, optimal detoxification requires specific conditions that are difficult to maintain in large-scale manufacturing, leading to variable detoxification efficiency. Additionally, compatibility strategies involving multiple herbs introduce complexity in standardizing formulations. Cost parity with conventional methods is challenging due to increased analytical testing and process controls, but long-term savings from reduced adverse events may offset initial investments.
How does the bidirectional toxicity-efficacy relationship impact dosage optimization in clinical practice?
The bidirectional relationship means that toxic and therapeutic effects are dose-dependent and can interconvert; low doses may be ineffective, while high doses cause toxicity. For example, aconitine exhibits cardiotoxicity at high doses but analgesic effects at lower doses. This necessitates individualized dosing based on metabolomic profiles and disease severity. Without precise 'component-toxicity' associations, dosage ranges remain restricted, often leading to underdosing and therapeutic failure or overdosing and toxicity. Integrating metabolomics and network toxicology can identify biomarkers for safe dosage windows, as shown in studies on Strychni Semen and rhododendron molle.
What are the economic and regulatory challenges in adopting advanced quality control for highly toxic TCM materials?
Advanced quality control requires significant investment in HPLC-MS instrumentation and skilled personnel, with costs per sample ranging from $100 to $500, which may be prohibitive for small manufacturers. Regulatory frameworks, such as the 2025 Chinese Pharmacopoeia, mandate strict limits but lack harmonization with international standards, complicating global trade. Additionally, the complexity of multi-component formulations makes it difficult to establish universal quality markers. However, the implementation of fingerprinting and metabolomic profiling can reduce liability and improve market access, as demonstrated by successful cases in aconite and strychnos products.
Related Chinese Research & Cross-Citations
A Novel Approach to Enhancing Mechanical Properties of Additively Manufactured Ti-6Al-4V Alloy via Friction Stir Processing
Additive manufacturing (AM) of Ti-6Al-4V alloy offers significant design freedom but often results in microstructural inhomogeneities and reduced mechanical properties compared to wrought counterparts. This study introduces a novel post-processing technique combining friction stir processing (FSP) with a subsequent heat treatment to refine the microstructure and enhance tensile and fatigue properties. The results demonstrate a 25% increase in yield strength and a 40% improvement in fatigue life, attributed to the elimination of porosity and the formation of a fine bimodal microstructure. The proposed method provides a scalable solution for improving the reliability of AM components in aerospace and biomedical applications.
Advanced Machine Learning Approaches for Predicting Material Properties in Metallurgical Processes
The accurate prediction of material properties is crucial for optimizing metallurgical processes and ensuring product quality. Traditional empirical models often fail to capture the complex nonlinear relationships inherent in these systems. In this study, we employ advanced machine learning (ML) techniques, including random forest, support vector regression, and deep neural networks, to predict key material properties such as tensile strength, hardness, and corrosion resistance based on process parameters and chemical composition. A comprehensive dataset from industrial trials and literature was compiled, and feature engineering was performed to enhance model performance. The models were trained and validated using cross-validation, and their predictive accuracy was compared against conventional regression methods. Results demonstrate that ML models significantly outperform traditional approaches, with the deep neural network achieving the highest accuracy (R² = 0.95). Furthermore, feature importance analysis revealed that cooling rate and alloying element concentrations are the most influential factors. The developed models provide a robust tool for real-time property prediction, enabling process optimization and quality control in metallurgical industries.
Optimization of Process Parameters for Additive Manufacturing of Ti-6Al-4V Alloy Using Machine Learning
Additive manufacturing (AM) of Ti-6Al-4V alloy is widely used in aerospace and biomedical industries due to its excellent mechanical properties and biocompatibility. However, the quality of AM parts is highly sensitive to process parameters such as laser power, scan speed, and layer thickness. This study presents a machine learning-based approach to optimize these parameters for improved density and mechanical strength. A dataset of 200 experimental runs was used to train and validate several regression models, including random forest, support vector regression, and neural networks. The random forest model achieved the highest prediction accuracy with an R² of 0.95. Multi-objective optimization using genetic algorithms identified optimal parameter sets that resulted in a 12% increase in tensile strength and a 15% reduction in porosity compared to baseline. The findings demonstrate the potential of machine learning in accelerating process optimization for AM, reducing trial-and-error costs, and enhancing part quality.
Advancements in High-Entropy Alloys: A Comprehensive Review of Microstructural Evolution and Mechanical Properties
High-entropy alloys (HEAs) have emerged as a novel class of materials with exceptional mechanical properties and thermal stability, making them promising candidates for advanced engineering applications. This comprehensive review synthesizes recent advancements in the microstructural evolution and mechanical performance of HEAs, focusing on the effects of alloying elements, processing routes, and heat treatments. Key findings highlight the role of severe lattice distortion and sluggish diffusion in enhancing strength and ductility. The review also discusses the challenges in predicting phase stability and the potential of computational approaches in accelerating alloy design. Finally, future research directions are outlined, emphasizing the need for scalable manufacturing and environmental sustainability.
A Novel Approach to Enhancing the Mechanical Properties of Additively Manufactured Ti-6Al-4V Alloy via In-situ Alloying with Boron
This study presents a novel approach to enhance the mechanical properties of additively manufactured Ti-6Al-4V alloy through in-situ alloying with boron. Boron was introduced into the titanium alloy matrix during the laser powder bed fusion process, resulting in a refined microstructure and improved tensile strength and ductility. The effects of boron content on the microstructure, phase composition, and mechanical properties were systematically investigated. The results demonstrate that the addition of 0.5 wt% boron leads to a significant grain refinement, with a reduction in prior β grain size from 200 μm to 50 μm. Consequently, the yield strength increased by 15% and the elongation improved by 20% compared to the unmodified alloy. The underlying strengthening mechanisms, including grain boundary strengthening and solid solution strengthening, are discussed. This work provides a promising pathway for tailoring the mechanical performance of additively manufactured titanium alloys for high-performance applications.
Optimization of Process Parameters for Laser Powder Bed Fusion of Ti-6Al-4V Alloy: A Machine Learning Approach
Laser powder bed fusion (LPBF) is a prominent additive manufacturing technique for producing complex Ti-6Al-4V components. However, the quality of printed parts is highly sensitive to process parameters, necessitating optimization. This study employs a machine learning approach to predict and optimize the effects of laser power, scan speed, and hatch spacing on the density and microhardness of LPBF-fabricated Ti-6Al-4V samples. A dataset of 50 experimental runs was used to train and validate several regression models, with the random forest algorithm achieving the highest prediction accuracy (R² = 0.95). Multi-objective optimization using a genetic algorithm identified optimal parameters (laser power: 200 W, scan speed: 1200 mm/s, hatch spacing: 0.08 mm) yielding a relative density of 99.8% and microhardness of 390 HV. The findings demonstrate the efficacy of machine learning in accelerating process optimization for LPBF, offering a cost-effective alternative to trial-and-error methods.